Lifefactors Zona Franca, SAS Report issue

For profit Phase 3
Founded: Antioquia Colombia (2018)
Status: No NME R&D (2018)

Organization Overview

First Clinical Trial
2020
NCT04395170
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Lifefactors Zona Franca, SAS

Active Ingredients

Drugs in Phase 3 Trials (1)

COVID-19 convalescent plasma (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1